Skip to main content

Reverse engineering Lewy bodies suggests α-synuclein pathology as condensatopathy.

bioRxiv : the preprint server for biology

Authors: Roberto Sansevrino, Aleksandr Korobeinikov, Jian-Hua Chen, Christian Hoffmann, Hugo Le Roy, Kiersten M Ruff, András Major, Asima Nayak, Paula Brosius, Axel Ekman, Shujin He, Michael Chen, Joshua Jackson, Gerard Aguilar Pérez, Han Wang, Johannes Vincent Tromm, Gwendolin Schneider, Kate Lau, Kathrin Textoris-Taube, Ludwig Sinn, Rinse de Boer, Lars T Hofstede, Jonas Franz, Mark A Le Gros, Silvio O Rizzoli, Tiago F Outeiro, Paolo De Los Rios, Vadim Demichev, Michael Mülleder, Markus Ralser, Dietmar Schmitz, Daniele Bano, Geert van den Bogaart, Yifan Dai, Alberto J Espay, Britta J Eickholt, Christine Stadelmann, Pallavi P Gopal, Rohit V Pappu, Tim Salditt, Carolyn Larabell, Dragomir Milovanovic

Understanding how soluble monomeric α-synuclein transitions into pathological α-synuclein (Lewy bodies) has remained a central challenge in neurodegeneration. Existing models, largely based on treating cells and animals with pre-formed α-synuclein fibrils cannot account for the emergence of the first inclusion without pre-existing seeds. Here, we combine in vitro reconstitutions, computational modeling and a minimal cellular system to show that phase separation of α-synuclein with an interacting scaffold can recapitulate Lewy body-like structures. An unbiased proteomics screen, live-cell imaging, correlative light-electron microscopy, and soft X-ray tomography show that Lewy body-like structures are associated with redistribution of actin and membrane-bound organelles, with mitochondria accumulating at their periphery in an actin-dependent manner. Structural analyses further indicate that α-synuclein condensates provide local environments in which the insoluble β-sheets can form. Together, these findings support a seed-independent trajectory from soluble α-synuclein through condensation and progressive immobilization to Lewy body-like assemblies and, subsequently, insoluble β-sheet fibrils. This framework offers a new mechanistic route for understanding the disease progression and promises to guide the design of innovative therapeutic interventions.

PMID: 42999318

Participating cluster members